Alpha Teknova (TKNO) Non-Current Assets (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Non-Current Assets of $67.0 million for Q1 2026, down 9.8% year-over-year from $74.3 million in Q1 2025, and down 3.03% quarter-over-quarter from $69.1 million in Q4 2025.
Alpha Teknova (TKNO) Non-Current Assets (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Non-Current Assets for 7 consecutive years, with $67.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 9.8% year-over-year to $67.0 million; the TTM figure through Mar 2026 stood at $279.5 million (down 9.38% YoY), while the FY2025 annual figure was $69.1 million, down 9.11% from the prior year.
- Non-Current Assets slipped to $67.0 million in Q1 2026 per TKNO's latest filing, from $69.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $101.9 million in Q2 2022 and bottomed at $67.0 million in Q1 2026.
- Historically, Non-Current Assets has averaged $82.1 million across 5 years, with a median of $82.0 million in 2024.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 87.89% — and 2023, when it dropped 12.25%.
- Alpha Teknova's Non-Current Assets stood at $91.1 million in 2022, then declined by 8.99% to $82.9 million in 2023, then declined by 8.36% to $76.0 million in 2024, then retreated by 9.11% to $69.1 million in 2025, then dropped by 3.03% to $67.0 million in 2026.
- Business Quant data shows TKNO's Non-Current Assets at $67.0 million in Q1 2026, $69.1 million in Q4 2025, and $71.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 65.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.05 Mn |
| Mar 31, 2026 | 66.98 Mn |
| Dec 31, 2025 | 69.07 Mn |
| Sep 30, 2025 | 71.06 Mn |
| Jun 30, 2025 | 72.43 Mn |
| Mar 31, 2025 | 74.26 Mn |
| Dec 31, 2024 | 75.99 Mn |
| Sep 30, 2024 | 78.17 Mn |
| Jun 30, 2024 | 80.07 Mn |
| Mar 31, 2024 | 81.99 Mn |
| Dec 31, 2023 | 82.93 Mn |
| Sep 30, 2023 | 87.31 Mn |
| Jun 30, 2023 | 89.44 Mn |
| Mar 31, 2023 | 91.39 Mn |
| Dec 31, 2022 | 91.12 Mn |
| Sep 30, 2022 | 90.21 Mn |
| Jun 30, 2022 | 101.92 Mn |
| Mar 31, 2022 | 92.15 Mn |
| Dec 31, 2021 | 65.31 Mn |
| Sep 30, 2021 | 58.08 Mn |